)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
ANI Pharmaceuticals
ANI Pharmaceuticals (ANIP) investor relations material
ANI Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary9 Apr, 2026
Executive summary
Annual meeting scheduled for May 21, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote online or during the meeting.
Voting matters and shareholder proposals
Election of seven directors is up for shareholder vote, with all nominees recommended by the board.
Ratification of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026.
Advisory vote on executive compensation (say-on-pay) and on the frequency of future say-on-pay votes, with the board recommending annual votes.
Approval of the Amended and Restated 2022 Stock Incentive Plan is proposed.
Provision to transact other business as may properly come before the meeting, including adjournments or postponements.
Board of directors and corporate governance
Seven director nominees are presented for election, including individuals with pharmaceutical and executive experience.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ANI Pharmaceuticals
- Record growth, robust governance, and expanded equity plan headline this year's proxy.ANIP
Proxy filing9 Apr 2026 - Rare disease, ophthalmology drive double-digit growth; sales force expansion to fuel future gains.ANIPLeerink Global Healthcare Conference 202619 Mar 2026
- Rare Disease portfolio drives robust growth, with Cortrophin and ILUVIEN poised for multi-year expansion.ANIPBarclays 28th Annual Global Healthcare Conference11 Mar 2026
- Rare Disease to drive 60% of 2026 revenue, with Cortrophin Gel fueling multi-year growth.ANIPCorporate presentation3 Mar 2026
- Rare disease growth and strong generics cash flow drive a projected $1B+ in 2026 sales.ANIP47th Annual Raymond James Institutional Investor Conference3 Mar 2026
- Record revenue and EBITDA growth in 2025, with Rare Disease leading and strong 2026 outlook.ANIPQ4 202527 Feb 2026
- ANI acquires Alimera for $381M, expanding rare disease and ophthalmology with strong synergies.ANIPM&A Announcement3 Feb 2026
- Record Q2 revenue growth and raised outlook driven by rare disease and generics momentum.ANIPQ2 20242 Feb 2026
- Rare disease and generics drive record growth, with 2024 revenue guidance up to $542 million.ANIPJefferies 2024 Global Healthcare Conference1 Feb 2026
Next ANI Pharmaceuticals earnings date
Q1 20268 May, 2026
ANI Pharmaceuticals
Next ANI Pharmaceuticals earnings date
Q1 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
)
Business philosophy22 Apr 2026
Benedetto Vigna: The CEO of Ferrari
An unexpected leader for Ferrari: how semiconductor expert Benedetto Vigna became CEO and why his background fits the industry's shift.
Frequently asked questions
Explore our global coverage